再灌注后对比增强与急性缺血性卒中患者降压治疗结局的关联
该研究基于BP-TARGET试验,纳入再灌注后行平板CT的164例患者,其中113例(68.9%)存在对比增强。分析显示,对比增强患者中强化降压组与标准降压组的脑出血风险无显著异质性,强化降压未显著增加脑出血风险。
要点
- 在对比增强患者中,强化降压组与标准降压组的脑出血风险无显著异质性(aOR=2.76,95%CI 0.80-9.48,p=0.11)。
- 强化降压组对比增强患者不良结局风险升高(aOR=2.91,95%CI 1.24-6.82),标准降压组无显著关联。
- 本研究提供IV级证据:对成功血管内治疗后对比增强的急性缺血性卒中成人,强化降压未显著增加脑出血风险。
核心结论
- 对比增强患者中,强化降压组与标准降压组相比,脑出血率或功能结局无显著差异,对比增强在两组均与脑出血风险升高相关,无显著异质性。
研究设计与样本
- BP-TARGET试验的事后分析,纳入再灌注后立即行脑平板CT的164例患者,随机分为强化降压组与标准降压组。
主要发现
- 164例患者中113例(68.9%)再灌注后存在对比增强。
- 强化降压组24小时平均收缩压显著低于标准降压组(129.7 vs 138.3 mm Hg,p<0.001)。
- 对比增强且随机至强化降压组者脑出血风险aOR=11.26(95%CI 4.59-27.63),对比增强且随机至标准降压组者aOR=4.08(95%CI 1.75-9.50),异质性检验aOR=2.76(95%CI 0.80-9.48,p=0.11)。
- 对比增强且随机至强化降压组者不良结局风险aOR=2.91(95%CI 1.24-6.82),标准降压组aOR=1.89(95%CI 0.85-4.23),组间异质性aOR=1.54(95%CI 0.48-4.97,p=0.47)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Observational studies described associations between higher systolic blood pressure (SBP) values and intracranial hemorrhages (ICHs) and worse outcomes after successful reperfusion by endovascular therapy (EVT). However, the BP-TARGET trial [BP-Target in Acute Ischemic Stroke to Reduce Hemorrhage after EVT] found that an intensive SBP target did not reduce ICH rates after successful EVT. The presence of contrast enhancement (CE) immediately after reperfusion is also associated with higher odds of ICH and worse outcomes. Our research question was to investigate the effect of 2 SBP strategies after reperfusion on ICH rates and functional outcomes according to the presence of CE in the BP-TARGET trial. We hypothesized that patients with CE could benefit from an intensive SBP control. METHODS: We included BP-TARGET patients in whom a brain flat panel was performed immediately after reperfusion. We described CE as present or absent, ICH consisted of any radiographic ICH 24 hours after EVT, and unfavorable outcome consisted of a modified Rankin Scale score between 3 and 6 at 3 months. RESULTS: Among the 324 patients randomized in BP-TARGET, 164 were included in this analysis, of whom 113 (68.9%) presented CE after reperfusion. The 24-hour mean SBP was significantly lower in the intensive SBP group compared with the standard group (129.7 vs 138.3 mm Hg, p < 0.001). Patients with CE and randomized in the intensive and standard SBP group had increased ICH rates: aOR = 11.26, 95% CI 4.59-27.63, and aOR = 4.08, 95% CI 1.75-9.50, respectively. However, the test of heterogeneity did not reach the significant level (aOR = 2.76, 95% CI 0.80 to 9.48, p = 0.11). Patients with CE and randomized in the intensive SBP group had also higher odds of unfavorable outcomes (aOR = 2.91, 95% CI 1.24-6.82), but this association was not significant in the standard SBP group (aOR = 1.89, 95% CI 0.85-4.23). No significant heterogeneity was found between the 2 groups (aOR, 1.54, 95% CI 0.48 to 4.97, p = 0.47). DISCUSSION: Altogether, patients with CE and randomized in the intensive SBP group did not have lower rates of ICH or improved outcomes compared with the standard SBP group, as CE was associated with higher odds of ICH in both groups, without significant heterogeneity. TRIAL REGISTRATION INFORMATION: NCT03160677. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for adults with contrast-enhancing lesions after successful EVT of an AIS, intensive blood pressure management did not significantly increase the risk of ICH.
引用
- Maïer B, Brauner R, Escalard S, et al. Association of Contrast Enhancement After Reperfusion With Outcomes According to Blood Pressure Lowering in Patients With Acute Ischemic Stroke. Neurology. 2022. PMID: 36041869. doi:10.1212/WNL.0000000000201173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。